Preparation of gelatin/epigallocatechin gallate self-assembly nanoparticles for transdermal drug delivery

Preparation of gelatin/epigallocatechin gallate self-assembly nanoparticles for transdermal drug... Atopic dermatitis (AD) is a relatively common inflammatory skin disease identified by swollen, cracked or inflamed skin. Currently, the primary treatments for AD are corticosteroids. However, after prolonged usage, corticosteroids have the potential to produce severe side effects. Epigallocatechin gallate (EGCG), a compound found in tea, provides anti-inflammatory properties that offer a potential alternative to corticosteroids in treating AD. However, the delivery method of EGCG greatly affects its bioavailability. The skin’s barrier makes it hard to delivery EGCG directly through intact skin. Nanoparticles provide an intriguing option for atopic transdermal delivery of EGCG due to their biochemical properties and ease of application. In this study, biodegradable self-assembling gelatin/EGCG nanoparticles (GE NPs) were synthesized for AD treatment. GE NPs had a spherical morphology with an average diameter of 112 nm and a zeta potential of nearly 23 mV. Cell viability assays indicated 10 μg/mL concentrations of EGCG or GE were non-toxic to human dermal fibroblast (WS1) cells. Intracellular quantification of dye conjugated GE was proceeded, and it revealed high amounts of fluorescence dye in cells. Lipopolysaccharide-inflamed WS1 cells were treated with EGCG solution or GE NPs, and IL-6 and IL-8 cytokine expression was assessed by ELISA method. GE NPs decreased inflammation as demonstrated by reducing IL-6 and IL-8 expression in WS1 cells in vitro with EGCG concentrations as low as 1 μg/mL. The topical delivery of GE NPs in vivo was examined by dropping different formulations on nude mice skin. GE NPs demonstrate greater skin absorbance than free EGCG in vivo and without eliciting adverse effects. This approach provides a novel alternative potential treatment for skin inflammatory diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Polymer Research Springer Journals

Preparation of gelatin/epigallocatechin gallate self-assembly nanoparticles for transdermal drug delivery

Loading next page...
 
/lp/springer_journal/preparation-of-gelatin-epigallocatechin-gallate-self-assembly-Ob9qbEKwya
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media B.V.
Subject
Chemistry; Polymer Sciences; Industrial Chemistry/Chemical Engineering; Characterization and Evaluation of Materials
ISSN
1022-9760
eISSN
1572-8935
D.O.I.
10.1007/s10965-017-1342-0
Publisher site
See Article on Publisher Site

Abstract

Atopic dermatitis (AD) is a relatively common inflammatory skin disease identified by swollen, cracked or inflamed skin. Currently, the primary treatments for AD are corticosteroids. However, after prolonged usage, corticosteroids have the potential to produce severe side effects. Epigallocatechin gallate (EGCG), a compound found in tea, provides anti-inflammatory properties that offer a potential alternative to corticosteroids in treating AD. However, the delivery method of EGCG greatly affects its bioavailability. The skin’s barrier makes it hard to delivery EGCG directly through intact skin. Nanoparticles provide an intriguing option for atopic transdermal delivery of EGCG due to their biochemical properties and ease of application. In this study, biodegradable self-assembling gelatin/EGCG nanoparticles (GE NPs) were synthesized for AD treatment. GE NPs had a spherical morphology with an average diameter of 112 nm and a zeta potential of nearly 23 mV. Cell viability assays indicated 10 μg/mL concentrations of EGCG or GE were non-toxic to human dermal fibroblast (WS1) cells. Intracellular quantification of dye conjugated GE was proceeded, and it revealed high amounts of fluorescence dye in cells. Lipopolysaccharide-inflamed WS1 cells were treated with EGCG solution or GE NPs, and IL-6 and IL-8 cytokine expression was assessed by ELISA method. GE NPs decreased inflammation as demonstrated by reducing IL-6 and IL-8 expression in WS1 cells in vitro with EGCG concentrations as low as 1 μg/mL. The topical delivery of GE NPs in vivo was examined by dropping different formulations on nude mice skin. GE NPs demonstrate greater skin absorbance than free EGCG in vivo and without eliciting adverse effects. This approach provides a novel alternative potential treatment for skin inflammatory diseases.

Journal

Journal of Polymer ResearchSpringer Journals

Published: Oct 17, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off